HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.

Abstract
Betulonic acid, derived from betulinol, a pentacyclic styrene, has shown a highly specific anti-prostate cancer activity in in vitro cell cultures. However, due to the lack of solubility of betulonic acid in aqueous medium, its potent anti-cancer activity in vivo has not been determined to the fullest extent. The present study describes the chemical synthesis of hydrophilic Boc-lysinated-betulonic acid, which has improved its solubility in an aqueous biocompatible solvent. Evaluation in cytotoxicity assays, Boc-lysinated-betulonic acid dissolved in phosphate-buffered saline (PBS) containing 22% ethanol and 4% human serum albumin, has shown 95.7% inhibition of LNCaP prostate cancer cells in culture after 72 h incubation at a concentration of 100 microM, but with little effect on normally proliferating fibroblast cells. In the in vivo assay, male athymic mice transplanted with human prostate LNCaP xenografts were injected with Boc-lysinated-betulonic acid intraperitoneally at a dose of 30 mg/kg daily for 17 days. The treated mice exhibited 92% inhibition of tumor growth as compared to controls. Histological sections of the tumors showed that Boc-lysinated-betulonic acid arrested mitosis and induced apoptosis, which was confirmed by TUNEL assay, Yo-Pro-1 staining, and the release of cleaved caspase-3 from the ex vivo in tumor culture. These studies, for the first time, demonstrate that a non-toxic hydrophilic lysinated derivative of betulonic acid and its solubility in a biocompatible aqueous medium has enhanced the bioavailability of the drug and has thus unleashed its full anti-prostate cancer activity.
AuthorsBrij B Saxena, Lei Zhu, Meirong Hao, Eileen Kisilis, Meena Katdare, Ozgur Oktem, Arkadiy Bomshteyn, Premila Rathnam
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 14 Issue 18 Pg. 6349-58 (Sep 15 2006) ISSN: 0968-0896 [Print] England
PMID16777417 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • betulonic acid
  • Oleanolic Acid
  • CASP3 protein, human
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases
  • Lysine
Topics
  • Animals
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Caspase 3
  • Caspases (drug effects)
  • Cell Proliferation (drug effects)
  • Drug Screening Assays, Antitumor
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Immunohistochemistry
  • In Vitro Techniques
  • Lysine (analogs & derivatives, chemistry)
  • Male
  • Mice
  • Mice, Nude
  • Mitosis (drug effects)
  • Molecular Conformation
  • Oleanolic Acid (analogs & derivatives, chemical synthesis, chemistry, pharmacology)
  • Prostatic Neoplasms (drug therapy, pathology)
  • Solubility
  • Stereoisomerism
  • Structure-Activity Relationship
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: